Treatment Optimization News Today

Experts on narcolepsy offer perspectives on non-pharmacologic interventions for pediatric patients with narcolepsy, including lifestyle changes.

Focusing on the case of a 9-year-old with excessive daytime sleepiness and sudden episodes of muscle weakness, the panel discusses the difficulty in diagnosing pediatric patients with narcolepsy.

Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA, discuss the complex case of a 23-year-old man who presents with excessive daytime sleepiness, cataplexy, hallucinations, and episodes of neurocardiogenic syncope.

Building upon the discussion of a complex case of a patient with narcolepsy, the panel provides clinical insights on cotreatment practices.

Focusing on the evaluation and management of narcolepsy, experts provide insights on clinical assessment practices and treatment classes.

Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA, offer comprehensive insights on how to diagnose narcolepsy, highlighting symptoms and diagnostic testing practices.

Experts on narcolepsy delve into the pathophysiology of the disorder, reviewing its underlying mechanisms and emphasizing the pivotal role of orexins in regulating sleep.

Karl Doghramji, MD, FAASM, DFAPA, and Chelsie Monroe, MSN, APN, PMHNP-BC, utilize their expertise in the management of sleep disorders to provide an overview of narcolepsy, educating the audience on how to recognize this condition in their patient populations.

Danielle Roman, PharmD, BCOP, discusses how the role of the oncology pharmacist has changed in recent years in optimizing early-stage breast cancer treatment with targeted therapies.

Kristen Peterson, PharmD, BCOP, reviews pharmacists’ pivotal role in optimizing patient transitions between inpatient and outpatient care settings to ensure treatment continuity and medication management in multiple myeloma care.